Acta Pharmaceutica Sinica B
|
2025, 15(7): 3824-3826
• Highlights •
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA₂ inhibitor
Full
Yangyihua Zhou1, Ning Shi1,2, Xiang Gao1, Longlong Luo1
Affiliations
1 State Key Laboratory of National Security Specially Needed Medicines, Beijing Institute of Pharmacology and Toxicology, Beijing 100080, China;
2 Xiangya School of Basic Medical Sciences, Central South University, Changsha 410078, China
doi: 10.1016/j.apsb.2025.05.019
Outline
Antivenom
/
Neutralizing antibody
/
PLA2 inhibitor
/
Triple-synergy strategy
Yangyihua Zhou, Ning Shi, Xiang Gao, Longlong Luo.
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA₂ inhibitor[J].
Acta Pharmaceutica Sinica B,
2025
, 15
(7)
: 3824
-3826
.
DOI: 10.1016/j.apsb.2025.05.019
Year 2025 volume 15 Issue 7
PDF
8
5
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.apsb.2025.05.019
- Receive Date:2025-05-13
- Online Date:2026-09-17